Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

BNTX BioNTech SE

93,12

0,00 (0,00%)

Avant marché

Dernière mise à jour : 10:07:07

Retardé de 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

The filing of this Form 144 shall not be construed as an admission that the undersigned is an affiliate of the issuer.

Date of Notice

02/20/2025

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Ugur Sahin

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

BioNTech (NASDAQ:BNTX)
Graphique Historique de l'Action
De Mar 2025 à Avr 2025

Plus de graphiques de la Bourse BioNTech

BioNTech (NASDAQ:BNTX)
Graphique Historique de l'Action
De Avr 2024 à Avr 2025

Plus de graphiques de la Bourse BioNTech

Actualités BioNTech SE

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Vendredi 4 Avril 2025 ( il y a 7 jours) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mercredi 2 Avril 2025 ( il y a 1 semaine) • Edgar (US Regulatory)

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Lundi 10 Mars 2025 ( il y a 1 mois) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Lundi 10 Mars 2025 ( il y a 1 mois) • Edgar (US Regulatory)

BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update
Lundi 10 Mars 2025 ( il y a 1 mois) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mardi 4 Mars 2025 ( il y a 1 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Jeudi 27 Février 2025 ( il y a 1 mois) • Edgar (US Regulatory)

BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025
Lundi 24 Février 2025 ( il y a 2 mois) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Jeudi 20 Février 2025 ( il y a 2 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Jeudi 20 Février 2025 ( il y a 2 mois) • Edgar (US Regulatory)

Moderna, BioNTech Shares Down After Senate Committee Vote To RFK Jr.’s Nomination
Mardi 4 Février 2025 ( il y a 2 mois) • IH Market News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Lundi 3 Février 2025 ( il y a 2 mois) • Edgar (US Regulatory)

Plus d'articles sur BioNTech SE

Jd Sports Fashion

Region de Bruxelles Capi...

RTE Electricity Transmis...

ABO Group Environment NV

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales